Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Antidepressant combos deliver improved outcomes in TRD
06 Apr 2025
bởiJairia Dela Cruz
Combination treatment with esketamine plus either a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI) is beneficial in treatment-resistant depression (TRD), with notable variations in outcomes depending on the choice of antidepressant class, as shown in a large retrospective study.